Evidence map›Paper›PMID 35148987›Full record

ArticleThe Journal of biological chemistry2022

Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain.

Cheng-Hui Lin, Yue Sun, Candace S Y Chan, Man-Ru Wu, Lei Gu, Alexander E Davis, Baokun Gu, Wenlin Zhang, Bogdan Tanasa, Lei R Zhong and 4 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Deep learning-guided design of cell type-specific AAV promoters.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Developing New Vectors for Retinal Gene Therapy.Cold Spring Harbor perspectives in medicine · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Cheng-Hui LinDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA.
Yue SunDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA; Department of Neurosurgery, Stanford University, Stanford, California, USA.
Candace S Y ChanDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA.
Man-Ru WuDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA.
Lei GuEpigenetics Laboratory, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Alexander E DavisDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA.
Baokun GuDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA.
Wenlin ZhangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Bogdan TanasaDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA.
Lei R ZhongDepartment of Neurosurgery, Stanford University, Stanford, California, USA.
Mark M EmersonDepartment of Biology, The City College of New York, New York, New York, USA.
Lu ChenDepartment of Neurosurgery, Stanford University, Stanford, California, USA.
Jun B DingDepartment of Neurosurgery, Stanford University, Stanford, California, USA; Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
Sui WangDepartment of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Stanford, California, USA. Electronic address: suiwang@stanford.edu.
Stanford University · USCity College of New York · USMax Planck Institute for Heart and Lung Research · DEStanford Medicine · USZhejiang University · CN

Funding

Role of synaptotagmins and neurexin ligands in homeostatic synaptic plasticityP50MH086403 · NIMH · STANFORD UNIVERSITY · PI DEISSEROTH, KARL A. · 2009 to 2019
$18.4M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Mechanisms regulating the plasticity of postmitotic cells in mammalian retinaR01EY032585 · NEI · STANFORD UNIVERSITY · PI WANG, SUI · 2021 to 2025
$2.0M
Retinal Muller Glial Cells in the initiation of diabetic retinopathyR01EY033792 · NEI · STANFORD UNIVERSITY · PI WANG, SUI · 2022 to 2025
$1.5M
Identification of factors controlling the genesis of cone photoreceptorsF32EY018287 · NEI · HARVARD MEDICAL SCHOOL · PI EMERSON, MARK M · 2008 to 2009
$101k
NEI NIH HHS F32 EY018287NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY032585NEI NIH HHS R01 EY033792NIMH NIH HHS P50 MH086403
6 · The paper itself

Abstract

Adeno-associated viruses (AAVs) targeting specific cell types are powerful tools for studying distinct cell types in the central nervous system (CNS). Cis-regulatory modules (CRMs), e.g., enhancers, are highly cell-type-specific and can be integrated into AAVs to render cell type specificity. Chromatin accessibility has been commonly used to nominate CRMs, which have then been incorporated into AAVs and tested for cell type specificity in the CNS. However, chromatin accessibility data alone cannot accurately annotate active CRMs, as many chromatin-accessible CRMs are not active and fail to drive gene expression in vivo. Using available large-scale datasets on chromatin accessibility, such as those published by the ENCODE project, here we explored strategies to increase efficiency in identifying active CRMs for AAV-based cell-type-specific labeling and manipulation. We found that prescreening of chromatin-accessible putative CRMs based on the density of cell-type-specific transcription factor binding sites (TFBSs) can significantly increase efficiency in identifying active CRMs. In addition, generation of synthetic CRMs by stitching chromatin-accessible regions flanking cell-type-specific genes can render cell type specificity in many cases. Using these straightforward strategies, we generated AAVs that can target the extensively studied interneuron and glial cell types in the retina and brain. Both strategies utilize available genomic datasets and can be employed to generate AAVs targeting specific cell types in CNS without conducting comprehensive screening and sequencing experiments, making a step forward in cell-type-specific research.

Indexed as

BrainDependovirusRetinaStaining and LabelingTranscription FactorsAnimalsBinding SitesChromatinMiceChromatinTranscription FactorsAAVsbraincis-regulatory module (CRM)glial cellneuronretinatranscription factorvirus

Identifiers

PMID35148987
PMCPMC8980332
OpenAlexW4211175592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.